1de Kruif, van Gorp EC, Keller TT,et al. Chlamydia pneumonia infections in mouse model: Relevance for atherosclerosis research [ J ]. Cardiovasc Res,2005,65(2) :317 -327.
2Erkkila L, Saario E, Laitinen K, et al. Intragastric primary infection sensitizes to lung re - infection in a Chlamydia pneumoniae mouse model [ J ]. Vaccine,2008,26 ( 20 ) : 2503 - 2509.
3Yang ZP, Kuo CC, Grayston JT. A mouse model of chlaydia pneumoniae strain TWAR pneumonitis [ J ]. Infect Immun, 1993,61 ( 5 ) : 2037 - 2040.
4Yang ZP, Kuo CC, Grayston JT. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice [ J ]. J Infect Dis, 1995,171 (3) :736 - 738.
5Moazed TC, Kuo CC, Patton DL, et al. Experimental rabbit models of chlamydia pneumoniae infection [J].Am J Pathol, 1996,148 (2) :667 - 676.
6Han X ,Wang S, Fan Y,et al. Chlamydia infection induces ICOS ligan- d - expressing and IL - 10 - producing dendritic ceils that can inhibit airway inflammation and mucus overproduction elicited by allergen challenge in BALB/c mice [ J ]. J Immunol, 2006,176 ( 9 ) : 5232 - 5239.
7Tammiruusu A, Penttila T, Lahesmaa R, et al. Intranasal administration of chlamydial outer protein 5/(CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model [ J ]. Vaccine,2007,25 (2) :283 - 290.
8Grayston JT, Campbell LA, Kuo CC,et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR [ J ]. J Infect Dis, 1990,161 (4) :618 -625.
9Hyman CL, Roblin PM, Gaydos CA, et al. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: Assessment by polymerase chain reaction - enzyme immunoassay and culture [ J ]. Clin Infect Dis, 1995,20 (5) : 1174 - 1178.
